Lakefront Biotherapeutics (LKFT) Cash from Investing Activities Growth (1y) (2017 - 2026)
Lakefront Biotherapeutics (LKFT) Cash from Investing Activities Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.86 Bn | -1.54 Bn | 1.91 Mn | -27.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.43% |
| Dec 31, 2025 | 6.24% |
| Mar 31, 2025 | 185.67% |
| Dec 31, 2024 | -10.53% |
| Mar 31, 2024 | 110.28% |
| Dec 31, 2023 | 321.89% |
| Mar 31, 2023 | 69.08% |
| Jun 30, 2020 | -4,020.01% |
| Mar 31, 2020 | 27,458.45% |
| Dec 31, 2019 | -36,380.25% |
| Sep 30, 2019 | -480.05% |
| Jun 30, 2019 | -89.23% |
| Mar 31, 2019 | -75.00% |
| Dec 31, 2018 | -247.13% |
| Sep 30, 2018 | 99.96% |
| Jun 30, 2018 | -100.05% |
| Mar 31, 2018 | -127.85% |
| Jun 30, 2017 | 225,074.85% |
| Mar 31, 2017 | 623.52% |